VaxFuture

─── A Think Tank for Smart Vaccine Cold Chain in China

From manufacturingto defining the futureof the industry

We use data, research and global benchmarks to define the next decade of China’s vaccine cold chain. Annual whitepapers, AI + digital twin foresight, and side-by-side comparisons with WHO, Gavi and UNICEF systems put every decision on higher ground.

Vol. 01 · Q2 / 2026

Editorial Brief

Within ten years, vaccine cold chain will undergo a second transformation

The first transformation moved vaccines from −20 °C bulk freezers to standardized +2~8 °C industrial chains. The second is now under way: from mechanical refrigeration to AI-driven, fully sensed smart cold chains.

— — — — — — — —

By the VaxFuture editorial board

─── Institute at a glance

5
Annual flagship whitepapers
50+
In-depth research articles
12
Global system benchmarks
36
Years of industry timeline
COVER3:4 · 900×1200VaxFuture《2026 年度中国疫苗冷链智能化白皮书》REPLACE WITH REAL IMAGE

─── Vol. 01 / 2026

China Vaccine Cold Chain Intelligence Whitepaper 2026

From Mechanical Control to AI-Sensed Smart Cold Chain: An Engineering Blueprint for the Second Revolution

This whitepaper systematically reviews the current state, bottlenecks and future trajectory of vaccine cold chain intelligence in China. Drawing on anonymized data from 30 pilot projects, twelve international system benchmarks and six in-depth interviews with industry leaders, it proposes an actionable five-year, three-stage engineering blueprint. The paper introduces a triadic technical framework of "digital twin + AI inspection + federated emergency response" and forecasts that by 2030 China will host the world’s largest and most advanced smart vaccine cold chain network.

  • 01China’s vaccine cold chain has reached the inflection point of a second revolution: sensor cost, edge compute and policy timing have arrived simultaneously
  • 02Per-warehouse digital twin cost will fall below ¥120,000 within five years, entering the affordability range of county-level CDCs
  • 03AI-driven smart replenishment lifts the hit rate of recommendations from 71% to 92%

─── Join the network

The future of the Institute is written together

We welcome policy researchers, CDC peers, pharma strategy teams, investors, university faculty, think tank fellows and international organization representatives to join our research network.